Products

Freespira
Freespira
Mental & Behavioral Health AI
Freespira is an FDA-cleared digital therapeutic that helps reduce or stop panic attacks and PTSD symptoms by teaching breathing regulation in just 28 days.

See all 1 product →

About Freespira

Freespira is a healthcare AI company that has developed an FDA-cleared digital therapeutic for the at-home treatment of panic disorder, panic attacks, and Post-Traumatic Stress Disorder (PTSD). The company’s solution combines a compact breathing sensor with a tablet and personalized coaching support. The core of the treatment is capnometry-guided respiratory intervention, which helps patients normalize their breathing patterns and reduce CO2 hypersensitivity, a physiological factor often associated with these conditions. The program is medication-free and designed to deliver rapid and lasting symptom relief within a 28-day course, with patients completing two 17-minute breathing sessions daily.

For physicians, Freespira offers an evidence-based, non-pharmacological adjunctive treatment option for patients diagnosed with panic disorder and/or PTSD. The treatment aims to correct underlying abnormal respiratory physiology by training patients to stabilize their breathing rate and exhaled CO2 levels. Clinical studies have indicated that a significant majority of patients experience a reduction or elimination of symptoms post-treatment, with benefits lasting at least a year. Furthermore, health economic outcome data suggests potential reductions in medical costs, including emergency department visits and pharmacy costs. Freespira can be integrated into patient care through referrals from various healthcare providers, including behavioral health, primary care, psychiatry, and case management, and post-treatment reports are available to providers.

Focus Areas

Digital Therapeutics Panic Disorder PTSD Anxiety Behavioral Health Respiratory Regulation

Business Intelligence

TechnologyThe Freespira system combines a compact breathing sensor with a tablet and a custom app. The sensor measures breathing rate and exhaled CO2 levels, providing real-time feedback to guide users in normalizing their breathing patterns. The platform also includes personalized coaching support.

What Physicians Need to Know

Specialization
Freespira specializes in Digital Therapeutics for Panic Disorder, PTSD, and Anxiety by addressing dysfunctional breathing patterns and CO2 hypersensitivity.
Key Differentiators
Freespira is the first FDA-cleared, medication-free, at-home digital therapeutic for panic disorder and PTSD. It offers a 28-day treatment protocol with real-time breathing feedback and personalized coaching.
Technology Stack
The Freespira system includes a compact breathing sensor that samples breathing through a nasal cannula, and a tablet with a dedicated app that provides real-time feedback on breathing patterns. It utilizes capnometry-guided respiratory intervention to help patients normalize CO2 levels and respiratory rates.
Clinical Efficacy
Clinical trials and real-world data show significant reduction or elimination of panic attacks and PTSD symptoms. For panic disorder, u226580% of patients reported significant reduction or elimination of symptoms post-treatment, with a majority maintaining clinical response through 12 months. For PTSD, 89% of patients reported a significant decrease in symptoms, and 50% were in remission at 6 months.
Cost Savings
Published health economic outcome data indicates significant reductions in medical costs (35%), emergency department visits (65%), and pharmacy costs (68%).
Physician Tip

For physicians, Freespira offers an FDA-cleared, evidence-based, and medication-free adjunctive treatment option for patients suffering from panic disorder and PTSD. It addresses the physiological root cause of these conditions by correcting dysfunctional breathing and CO2 hypersensitivity. The at-home nature of the treatment, combined with personal coaching, can improve patient adherence and accessibility, especially for those who may struggle with traditional in-person therapies or medication side effects. Physicians can refer patients via the Freespira website, phone, or fax, and receive post-treatment reports. It can be used alongside existing pharmacological and/or non-pharmacological interventions.

Freespira is designed as an at-home system that includes a breathing sensor and a tablet with a dedicated app. The data from the sensor is transmitted via Bluetooth to the tablet. While the core treatment is self-contained, Freespira provides weekly check-ins with a care coordinator/coach, which can be done via secure video. Freespira also works with health plans, self-insured employers, and the Veterans Administration for patient access and coverage.

Products by Freespira

1 product in the directory

Freespira
Freespira
Mental & Behavioral Health AI
Freespira is an FDA-cleared digital therapeutic that helps reduce or stop panic attacks and PTSD symptoms by teaching breathing regulation in just 28 days.

What the Web Says

Freespira is an FDA-cleared, at-home breathing-based treatment for panic attacks, panic disorder, and PTSD symptoms. The program involves twice-daily 17-minute sessions using a sensor and tablet with real-time feedback, along with weekly coaching from a Care Specialist. Many users have reported significant reductions in panic attacks and PTSD symptoms, improved sleep, and a greater sense of control over their anxiety.

Overall: Positive

Strengths

  • Clinically proven and FDA-cleared for panic disorder and PTSD.
  • Medication-free with low to no side effects.
  • Provides fast and long-lasting relief, with some users reporting improvement within two weeks and benefits persisting a year post-treatment.
  • Teaches self-management skills to regulate breathing patterns and reduce CO2 sensitivity, a known trigger for panic attacks.
  • Convenient at-home program with equipment mailed directly to the user and online support from coaches.
  • Positive customer service experiences, with staff described as friendly, helpful, and knowledgeable.

Limitations

  • Some users find the program expensive.
  • Potential for initial discomfort or anxiety during breathing sessions, especially for individuals with anxiety around breathing.
  • Technical issues with equipment connection and scheduling difficulties with coaching appointments have been reported.
  • One user felt it was no more effective than a free breathing app for PTSD.
  • Lack of extensive independent reviews on platforms like Reddit, leading to some skepticism.

Based on reviews from: Reddit, Freespira.com (Customer Reviews), TelepsychHealth

Last updated: 2026-09-19

Videos

News, demos, and interviews about Freespira.

Loading videos...

Videos load interactively. If none appear, search YouTube for Freespira →

View all on YouTube

Press & Coverage

Business Wire
Freespira Receives FDA Clearance for Adolescents Ages 13u201317; Clinically Validated, At-Home Treatment Reduces Panic Disorder Symptom Severity by 54% and PTSD Symptom Severity by 44%
Freespira, Inc. announced FDA 510(k) clearance to extend its at-home treatment for anxiety disorders, including panic disorder and PTSD, to adolescents aged 13u201317. This makes Freespira the only prescription, medication-free treatment targeting physiological root causes of these conditions in this age group.
2025-05
PR Newswire
FREESPIRA ANNOUNCES LAUNCH OF ITS 5TH GENERATION DEVICE, MARKING THE MOST ADVANCED MEDICAL DEVICE FOR THE TREATMENT OF STRESS AND ANXIETY DISORDERS
Freespira launched its fifth-generation device, Freespira Sensor Technology v5 (FST5), which integrates the sensor and display into a single user-friendly unit. This device is an FDA-cleared at-home treatment for anxiety disorders, including panic disorder and PTSD.
2026-02
PR Newswire
Freespira Introduces the Zero Risk Program for Health Plans, a First for Mental Health Devices
Freespira announced its 'Zero Risk' program for health plans, a performance guarantee designed to reduce the risks for payers covering its FDA-cleared at-home treatment for anxiety disorders. This program aims to improve access to care and follows their recent FDA indication for adolescents.
2025-10
Medtech Insight
Breathing Easy: Freespira Works To Expand Access To Panic And PTSD Treatment
Freespira's FDA-approved device treats panic disorders, PTSD, and anxiety in teens through behavioral techniques and respiratory tracking. CEO Joe Perekupka highlighted the company's focus on patient coaching, insurance partnerships, and lobbying for broader insurance coverage for digital therapeutics.
2025-08
Life Science Washington
FDA Clears Freespira for Teens 13-17; At-Home Treatment Cuts Panic and PTSD Symptoms
Freespira, Inc. received FDA 510(k) clearance to extend its at-home treatment for panic disorder and PTSD to adolescents aged 13-17. This drug-free therapy targets the physiological root causes of these conditions using real-time, software-guided breathing and personalized coaching.
2025-05
GeekWire
Seattle-area company lands FDA clearance for drug-free treatment to address teen anxiety and trauma
Freespira received FDA clearance to treat adolescents aged 13-17 with its drug-free technology, which provides breathing training and video-based coaching for anxiety, panic attacks, and trauma. Clinical trials showed significant symptom reduction in adolescent patients.
2025-05
Medical Device Innovation Consortium
Freespira's Strategic Approach to Market Access
Freespira's strategic approach to market access for its FDA-cleared digital therapeutic for panic disorder and PTSD is highlighted. The company demonstrated clinical efficacy and economic value to payers, including a 35% reduction in total medical costs.
2024-08
Frontiers in Digital Health
Real-world outcomes of an innovative digital therapeutic for treatment of panic disorder and PTSD: A 1,500 patient effectiveness study
This real-world study evaluated Freespira's effectiveness in over 1,500 patients with panic disorder and PTSD, showing significant reductions in symptoms and healthcare costs. The intervention, which received FDA clearance in 2013 for panic disorder and 2018 for PTSD, targets dysfunctional breathing patterns.
2022-10

Frequently Asked Questions

Freespira is an FDA-cleared digital therapeutic that provides an at-home, medication-free treatment for symptoms associated with panic disorder, panic attacks, and PTSD. It works by training patients to normalize their breathing patterns, specifically addressing dysfunctional breathing linked to CO2 hypersensitivity, which is often associated with these conditions. The program involves twice-daily 17-minute sessions over 28 days, using a compact breathing sensor and a tablet with real-time feedback.
Freespira has demonstrated consistent clinical outcomes across multiple published studies. For panic disorder, over 80% of patients reported significant symptom reduction or elimination post-treatment, with a majority maintaining this response for 12 months. In PTSD trials, 89% of patients showed a significant decrease in symptoms, and 50% were in remission at 6 months. Adherence rates have been reported around 77% for PTSD and 84% for panic disorder.
The out-of-pocket cost for the Freespira program is approximately $2,000. However, many individuals, including veterans with VA benefits, may have Freespira covered by their health insurance or employer. Freespira also offers outcomes-based pricing and performance guarantees for health plans, aligning costs with clinical improvement and potential healthcare savings.
Freespira provides support through care specialists who guide patients weekly, monitoring progress and answering questions. For healthcare providers, Freespira offers referral pathways via website, phone, or fax, and can provide post-treatment reports for patients. They also work with health plans, employers, and government contractors like Lovell Government Services to expand access and offer clinician support, particularly for Veterans Administration healthcare providers.
Freespira partners with health plans, employers, providers, and aggregators to expand access to their digital therapeutic. Notable partnerships include Highmark Health, Children's Community Health Plan, and the Veterans Administration, which offer Freespira as a covered benefit. They also work with organizations like Brighton Marine and IBH Population Health Solutions to integrate Freespira into their behavioral health programs.
Freespira is an FDA-cleared Class II medical device. It is indicated as an adjunctive treatment for symptoms associated with panic disorder and/or PTSD for adults 18 years of age or older. Freespira has also received FDA clearance for treating stress and anxiety symptoms in adolescents aged 13-17.
Freespira is not indicated for patients younger than 13 years old, those who are pregnant, or individuals with chronic obstructive pulmonary disease (COPD) or emphysema.

Related Companies

TimeDoc Health is a healthcare technology and services company that provides virtual care management solutions, primarily focusing on chronic care management (CCM), remote patient monitoring (RPM), and behavioral health integration (BHI). Their platform and services are designed to help healthcare organizations, including primary care providers, health systems, FQHCs (Federally Qualified Health Centers), and Medicare Advantage […]

PMHScribe is an AI-powered clinical documentation tool specifically designed for psychiatrists, Psychiatric Mental Health Nurse Practitioners (PMHNPs), therapists, and other behavioral health clinicians. Unlike generic AI scribes, PMHScribe is built to understand the unique workflows and documentation requirements of mental healthcare, generating structured notes such as SOAP, DAP, and BIRP notes. The platform aims to […]

PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]

MedLaunch is an AI-powered healthcare IT company that focuses on diagnosing and resolving operational inefficiencies in small to mid-size outpatient clinics, including general practice, specialty, and allied health. They aim to reduce administrative overhead, improve patient flow, and protect revenue through purpose-built AI solutions. MedLaunch emphasizes deep healthcare industry expertise, end-to-end digital solution implementation, and […]

Steer Health is an AI-powered growth and automation platform designed to optimize patient experiences and enhance revenue for healthcare organizations. The company’s platform utilizes artificial intelligence to automate various administrative tasks, including eligibility checks, referrals, payments, and patient intake. This automation facilitates personalized online scheduling, appointment reminders, and patient communication services, ultimately aiming to improve […]

Xealth is a healthcare AI company that provides a care orchestration platform designed to seamlessly integrate digital health tools and programs into existing clinical workflows. For physicians, this means the ability to prescribe and monitor digital health content, applications, and services directly from within their Electronic Health Record (EHR) system, much like ordering traditional medications. […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.